Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aortic Regurgitation IV: Nursing Management01:17

Aortic Regurgitation IV: Nursing Management

A nurse managing a patient with aortic regurgitation begins with a comprehensive assessment, including a review of the patient's medical history, family history, and lifestyle factors. During the cardiac examination, the nurse listens for heart sounds and checks for signs of valve abnormalities. The nurse also observes for symptoms such as dyspnea, orthopnea, and paroxysmal nocturnal dyspnea and assesses the patient's endurance and daily activity tolerance.Based on the findings, the nurse...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ability of artificial intelligence to correctly predict inpatient versus observation hospital discharge status.

Proceedings (Baylor University. Medical Center)·2025
Same author

Characterization of acute residual pulmonary vein connections using electroanatomic mapping during pulsed-field ablation of atrial fibrillation.

Heart rhythm·2025
Same author

ACC/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2024 Appropriate Use Criteria for Multimodality Imaging in Cardiovascular Evaluation of Patients Undergoing Nonemergent, Noncardiac Surgery.

Journal of the American College of Cardiology·2024
Same author

Percutaneous Coronary Intervention Without On-Site Surgical Backup-The Times They Are A-Changin'.

Journal of the Society for Cardiovascular Angiography & Interventions·2024
Same author

Obesity Conundrum.

The American journal of cardiology·2024
Same author

Heart Rate.

The American journal of cardiology·2024

Related Experiment Video

Updated: Jun 17, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Enhanced external counterpulsation is a regenerative therapy.

Coty W Jewell1, Philip D Houck, Linley E Watson

  • 1Department of Medicine, Cardiology Division, University Health Science Center College of Medicine and the Scott and White Clinic, Temple, Texas 76513, USA.

Frontiers in Bioscience (Elite Edition)
|December 29, 2009
PubMed
Summary

Enhanced external counterpulsation (EECP) therapy may boost circulating stem cells, suggesting a regenerative mechanism for its long-term benefits in heart patients. This study explored EECP

More Related Videos

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

Related Experiment Videos

Last Updated: Jun 17, 2026

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets
08:08

Increasing Pulmonary Artery Pulsatile Flow Improves Hypoxic Pulmonary Hypertension in Piglets

Published on: May 11, 2015

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

Area of Science:

  • Cardiovascular Medicine
  • Regenerative Medicine
  • Stem Cell Biology

Background:

  • Enhanced external counterpulsation (EECP) offers clinical benefits for severe angina and heart failure, extending beyond immediate hemodynamic effects.
  • The underlying mechanism for EECP's prolonged therapeutic impact remains unclear, prompting investigation into regenerative processes.
  • The regenerative potential of EECP is hypothesized to involve the enhancement of circulating stem cells.

Purpose of the Study:

  • To investigate whether EECP therapy increases the number of circulating hematopoietic progenitor cells (HPCs) and endothelial progenitor cells (EPCs).
  • To explore the potential of EECP as a regenerative therapy by assessing its impact on stem cell populations.
  • To elucidate the mechanism by which EECP might stimulate regenerative circulating stem cells.

Main Methods:

  • EECP therapy was administered to patients with severe angina or heart failure.
  • Blood samples were collected to quantify circulating hematopoietic progenitor cells (HPCs) and endothelial progenitor cells (EPCs).
  • The study analyzed the correlation between EECP treatment and changes in HPC and EPC levels.

Main Results:

  • EECP therapy was associated with an increase in circulating hematopoietic progenitor cells (HPCs).
  • A significant rise in endothelial progenitor cells (EPCs) was observed following EECP treatment.
  • These findings support the hypothesis that EECP enhances regenerative stem cell populations.

Conclusions:

  • EECP therapy demonstrably increases circulating hematopoietic progenitor cells (HPCs) and endothelial progenitor cells (EPCs).
  • The observed increase in stem cells suggests a regenerative mechanism underlying EECP's sustained clinical benefits.
  • EECP may function as a regenerative therapy by stimulating the release and circulation of progenitor cells, potentially via enhanced shear forces.